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http://dx.doi.org/10.1016/j.hkjot.20Summary Background: Dyspnoea is crucial in evaluating patients with chronic obstructive
pulmonary disease (COPD). The San Diego Shortness of Breath Questionnaire (UCSD SOBQ)
assesses shortness of breath in activities of daily living (ADL). It has been translated into
Chinese and used clinically in Hong Kong for many years.
Objective: To investigate the reliability and validity of a self-administered Chinese version of
the Shortness of Breath Questionnaire (C-SOBQ) with pictorial enhancement in patients with
COPD in Hong Kong.
Methods: A total of 119 patients with COPD were recruited by convenience sampling from
seven public clinical settings and two community self-help groups. The C-SOBQ score for each
patient was correlated with a set of criterion parameters including age, body mass index (BMI),
6-minute walking distance (6MWD) test, lung function physiological parameters, BODE index,
the Modified Medical Research Council Dyspnoea Scale (MMRC Dyspnoea Scale), and the Global
Initiative for Chronic Obstructive Lung Disease (GOLD) COPD classifications. For testeretestck, Occupational Therapy Department, Tung Wah Eastern Hospital, Hong Kong Special Administrative
A. Fung).
vier (Singapore) Pte. Ltd. All rights reserved.
12.12.010
76 A. Fung et al.reliability, 22 out of 119 patients were selected and assessed using the C-SOBQ followed by
a reassessment within 1 week by the same rater.
Results: The C-SOBQ shows good testeretest reliability with an intra-class correlation coeffi-
cient of 0.915 (p & .05). It demonstrates significant correlations with the MMRC Dyspnoea
Scale, GOLD COPD classifications, BODE index, BMI, and 6MWD. The BODE index, MMRC
Dyspnoea Scale, and 6MWD were valid predictors of C-SOBQ total score. A total of 50.4% of
patients could be correctly grouped in quartiles of the BODE index using the C-SOBQ.
Conclusion: The C-SOBQ with pictorial enhancement is a valid and reliable instrument which
gives precise information about the impact of dyspnoea on functional activities for patients
with COPD.
Copyright ª 2013, Elsevier (Singapore) Pte. Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a major
cause of chronic morbidity and mortality around the world.
It is projected that by 2020 it will rank fifth in terms of
worldwide burden of disease, according to the World Health
Organization (WHO, 2006). In Hong Kong, the prevalence
was estimated in 2000 to be 139,000 or 3.5% of the total
population (Regional COPD Working Group, 2003). COPD is
characterised by airflow limitation that is not fully rever-
sible, is usually progressive, and is associated with an
abnormal inflammatory response of the lung (Global
Initiative for Chronic Obstructive Lung Disease [GOLD],
2011). The airflow limitation is confirmed by an objective
spirometry test. However, such a measure only gives
information on one aspect of the disease process: the air-
flow abnormality in the lungs. This is often inadequate to
reflect the multifaceted problems actually caused by the
disease. Patients are usually unaware of the pathophysio-
logical changes in their bodies and they only seek medical
attention when distressing symptoms such as exertional
dyspnoea and exercise limitation begin to appear. There-
fore, it is instrumental to directly assess the symptoms of
patients in order to understand the impact of the disease
process as well as to define outcomes following
interventions.
The ATS (2002) defines dyspnoea as a symptom used to
characterise a subjective experience of breathing dis-
comfort that consists of qualitatively distinct sensations
that vary in intensity. Such subjective experience derives
from interactions among multiple physiological, psycho-
logical, social, and environmental factors, and may induce
secondary physiological and behavioural responses. Expe-
riencing shortness of breath (SOB) and a decline in physical
tolerance are often the causes of disability for persons with
COPD in performing activities of daily living (ADL) (Chan,
Tam, Chan, Ng, & So, 2006; Fong et al., 2001). Eakin,
Kaplan, Ries, & Sassi-Dambron (1996) show that self-
reported dyspnoea is an important and independent out-
come measure of COPD, and it has therefore become an
important area of research interest. An accurate assess-
ment reflecting the level of self-reported dyspnoea that the
patients are experiencing is essential in clinical practice
both for differentiating between patients who have less and
those who have more dyspnoea (discriminative), and
determining whether their dyspnoea has changed over timeand/or as a result of treatment (evaluative). Although
many methods are available to evaluate breathlessness in
COPD, their effectiveness and clinical utility remain largely
unexplored in the respiratory care literature.
The key requirements of the self-reported assessment
tool should be: (a) a patient-reported outcome; (b) multi-
dimensional, but simple to use; (c) responsive to therapy
with the ability to detect change; and (d) an established
minimal clinically important difference (Cullen & Rodak,
2002; Mahler, 2006). The University of California San
Diego Shortness of Breath Questionnaire (UCSD SOBQ) is
a self-administered questionnaire developed primarily as
a screening evaluation for rehabilitation programme to
assess the self-reported dyspnoea associated with specific
ADL (Eakin, Resnikoff, & Prewitt, 1998). It meets all the
above requirements and, in addition, its broader coverage
of items in ADL and its wider gradation (0e120) may offer
advantages over other, similar instruments (Eakin et al.,
1998; Kupferberg, Kaplan, Slymen, & Ries, 2005).
The aims of this study were: to develop a self-
administered Chinese SOBQ with pictorial enhancement
(C-SOBQ); to investigate its testeretest reliability and
criterion-related and discriminative validities; and to
improve the clinical application of the instrument in local
communities, especially among the illiterate, and across
populations of different languages and cultures (such as
Chinese not of Guangzhou origin, Caucasians, and so on).
The study primarily intended to establish the instrument’s
reliability and validity.Methods
Participants
This was a cross-sectional study employing a convenience
sample of 115 patients suffering from COPD of various
severities and whose medical conditions were stable. They
were recruited from five public hospitals, two outpatient
clinics, and two community COPD self-help groups. Patients
with different disease severities were staged according to
the GOLD guidelines (2011). Participants were required to
meet the selection criteria: (1) diagnosed with COPD with
a ratio of forced expiratory volume in 1 second (FEV1) to
forced vital capacity (FVC) of less than 70%; (2) stable
condition (no admissions related to respiratory problem in
Chinese shortness of breath questionnaire 77the 4 weeks prior to assessment); and (3) no current or
recurrent symptomatic ischaemic heart disease, lung
cancer, known psychiatric illness, active tuberculosis, un-
controlled insulin-dependent diabetes mellitus, and active
exacerbation of COPD. Twenty-two out of the 115 patients
were randomly recruited from the seven clinical settings
for testeretest reliability purposes and were assessed by
the C-SOBQ followed by a reassessment within 1 week by
the same rater.
Design
To establish testeretest reliability, all patients were
assessed using the C-SOBQ followed by a reassessment
within 1 week by the same rater. The first and second sets
of scores were then analysed. To establish criterion-related
validity, the C-SOBQ was correlated with seven criterion
parameters in four domains: (1) physical parameter in terms
of age and body mass index (BMI); (2) exercise capacity by
the 6-minute walking distance (6MWD) test; (3) physiologi-
cal parameters by means of lung function impairment as
measured by spirometry in terms of FEV1, FVC, the ratio of
FEV1 and FVC (FEV1/FVC), and the predicted values of
FEV1 and FVC; and (4) the impairment level of COPD in
terms of the GOLD classification and score on the Modified
Medical Research Council Dyspnoea Scale (MMRC Dyspnoea
Scale). The C-SOBQ scores of the 115 participants were
used to predict the GOLD COPD classification, the MMRC
Dyspnoea Scale score, and the BODE index by means of
discriminative analysis. The parameters were collected
from the medical records of each selected patient within
a 1-month interval. If those were not available, assessments
were conducted by occupational therapy students under the
direct supervision of registered occupational therapists.
Instruments
C- SOBQ (Appendix I)
The UCSD SOBQ is a valid and reliable instrument for
assessing the impact of dyspnoea on ADL for patients with
different lung diseases (Eakin et al., 1998). The C-SOBQ was
translated from the UCSD SOBQ with the author’s permis-
sion. It contains 24 items rated using a scoring scale from
0e5. The C-SOBQ is a self-administered questionnaire
which asks patients to indicate the severity of their short-
ness of breath on a six-point scale (where 0Z not at all and
5 Z maximal or unable to do because of breathlessness)
during 21 different ADL associated with varying levels of
exertion. Three additional questions about limitations
because of shortness of breath, fear of harm from over-
exertion, and fear of shortness of breath are included to
make up the total of 24 items.
The content validity of the instrument, instructions and
testing procedures of the C-SOBQ were verified by a panel
comprised of one expert from Hong Kong Polytechnic
University and nine occupational therapists with intensive
experience of working with COPD patients in public
hospitals.
The 24 items were presented to the participants using
picture cards representing the specific tasks of ADL. The
cards were illustrated in black-and-white cartoon style inorder to accommodate patients with decreased visual
sensitivity to colour contrast. Six A4-sized scoring cards
printed with different dyspnoea scores (0e5) were also
placed on a desk in front of the participant. The ADL
picture cards were then given one by one and the patient
asked to score the subjective dyspnoea level of each spe-
cific ADL activity by placing the presented ADL picture card
on one of the corresponding scoring cards. Patients’
response should be for an average day during the past
week. If patients did not routinely perform the activity,
they were asked to estimate the degree of shortness of
breath anticipated. The C-SOBQ was scored by summing
responses across all 24 items to form a total score ranging
from 0 to 120.
In the rating scale of the original SOBQ, there were no
descriptive wordings for scale points 1e3. However, the
panel decided to use descriptive wordings for all five points
throughout the study to make the scale clearer and more
understandable. They are: 0 Z Not at all, 1 Z Very mild,
2Z Mild, 3Z Moderate, 4Z Severely, and 5 Z Maximally
or unable to do because of breathlessness. Face validity
was carried out to determine whether the pictorial illus-
trations precisely represented the corresponding ADL tasks
(questions 1e21). A field test of 20 participants with COPD
was conducted twice with the prototype C-SOBQ, one of
which included descriptive wordings and one which did not.
The results did not identify any significant differences in
the final scores between the two questionnaires, suggesting
that the intended adaptations did not alter the construct of
the rating scale.
The COPD stage (Appendix II)
The disease severity of patients was classified into four
COPD stages: Stage 1 Z Mild, Stage 2 Z Moderate, Stage
3Z Severe, and Stage 4Z Very Severe, as according to the
GOLD spirometry classification guidelines (GOLD, 2011).
The MMRC Dyspnoea Scale (MMRC) (Appendix III)
The MMRC dyspnoea scale is a measure of disability in
patients with COPD and is recognised as a simple discrim-
inative measure of functional dyspnoea levels (Eltayara,
Becklake, & Volta, 1996). It is an ordinal five-point scale
based on the degree of exertional levels of various physical
activities that precipitate dyspnoea. Patients are asked
about their perceived breathlessness and classified into the
five dyspnoea grades (from 0 Z minimal to 4 Z maximum)
(Mahler & Wells, 1988). The MMRC is also used to construct
the BODE index.
The BODE index (Appendix IV)
The BODE index is a tool recently proposed to provide
prognostic information about COPD patients (Amoro´s, Mas-
tous, & Renom-sotorra, 2009; Celli, Cote, & Martin, 2004).
It is used to predict COPD mortality. BODE refers to the BMI
(B), the degree of airflow obstruction (O), dyspnoea (D),
and exercise capacity (E) and is a simple multidimensional
10-point scale in which higher scores indicate a higher risk
of death (Callens et al., 2009; Celli et al., 2004). The total
score is calculated using four parameters (Appendix II).
The BODE score can be classified into four quartiles and
each quartile increase in BODE score is associated with
Table 1 Demographic Characteristics of Patients with
COPD.
Characteristics (n Z 115) Mean SD
Age (y) 73.92 9.12
BMI 21.31 3.58
6MWD (m) 317.58 112.23
FEV1 (L) 0.96 0.46
78 A. Fung et al.increased mortality: Quartile 1 Z BODE 0e2, Quartile
2 Z BODE 3e4, Quartile 3 Z BODE 5e6, and Quartile
4 Z BODE 7e10 (Celli et al., 2004).
Spirometry lung function test
A spirometry test was conducted according to the Ameri-
can Thoracic Society/European Respiratory Society (ATS/
ERS) Standardization Guidelines (Miller, 2005) using a spi-
rometer. It measured the volume of air forcibly exhaled
from the point of maximum inspiration (FVC) and the
volume of air exhaled during the first second of this
manoeuvre (FEV1). The ratio of these two figures (FEV1/
FVC) was then calculated. The predicted values of FEV1
and FVC in this study were calculated using the Hong Kong
norms of lung function according to the equations for
males and females (Ip et al., 2006). In this study, the
degree of airflow obstruction from spirometry is also used
as a variable to construct the BODE index. Lower limit for
normal (LLN) of FEV1/FVC ratio for males was calculated
as: [0.00932 þ (Age  1.409  105 ) þ (Age2  3.038 
107) þ (Height  4.001  105)]  Height2, and LLN
of FEV1/FVC ratio for females: [0.01119 þ (Age 
1.062  105) þ (Age2  2.046  108) þ
(Height  4.900  105)]  Height2.
6MWD
The self-paced 6MWD is a submaximal exercise test, but it
correlates well with the maximal cardiopulmonary exercise
test (Carter et al., 2003). It is frequently used to assess the
level of exercise capacity of patients suffering from COPD.
In this study, the 6MWD was measured by the distance that
a patient could walk quickly on a flat hard surface over
a period of 6 minutes. Short breaks were allowed if
necessary. Pulse rate and oxyhaemoglobin percentage (%
SpO2) were recorded before, during, and after the test. The
6MWD is one of the variables used to construct the BODE
index.
BMI
BMI is the weight in kilograms divided by the square of the
height in metres. There is an inverse relation between BMI
and survival and index values below 21 are associated with
an increased risk of death as reported by Celli et al. (2004).
The BMI is also used to construct the BODE index.FVC (L) 1.98 0.66
FEV1 /FVC (%) 48.27 13.50
FEV1 % predicted (%) 45.87 20.19
FVC % predicted (%) 68.69 20.61
BODE Index 4.17 2.53
MMRC 1.92 1.01
GOLD COPD Stage 2.80 0.90
C-SOBQ 40.83 26.89
Note. 6MWD Z 6-minute walking distance; BMI Z body mass
index; COPD Z chronic obstructive pulmonary disease;
C-SOBQ Z Chinese version of the Shortness of Breath Ques-
tionnaire; FEV1 Z forced expiratory volume in 1 second;
FVC Z forced vital capacity; FEV1 % predicted Z predicted
value of forced expiratory volume in 1 second; FVC %
predicted Z predicted value of forced vital capacity;
GOLDZ Global Initiative for Chronic Obstructive Lung Disease;
MMRC Z Modified Medical Research Council Dyspnoea Scale;
SD Z standard deviation.Statistical analysis
Descriptive statistics were used to present the patients’
demographic data. The testeretest reliability of the
C-SOBQ was determined using the intraclass correlation
coefficient (ICC) (two-way mixed effect model) with a 95%
confidence interval. A sample size of 22 patients for the
testeretest reliability by ICC was determined based on
a predicted value of ICC ranged from 0.8 to 0.9 with a 0.05
confidence limit (Walter, Eliasziw, & Donner, 1998). This
reports the proportion of variance of an observation
because of between-subject variability in the true scores.
The ICC ranges between 0.0 and 1.0. The correlation of the
C-SOBQ with criterion-related parameters was calculated
using Spearman’s rank correlation coefficient over the 115
patients. Stepwise multiple linear regression analysis wasalso used to analyse the relationships between the vari-
ables including the BODE index, COPD classification, MMRC
scale, 6MWD, lung function test (FEV1, FVC, FEV1/FVC,
FEV1% predicted, FVC% predicted) and BMI as a predictor of
the C-SOBQ total score. The level of significance was set at
p  .05. To investigate the discriminative ability of the
C-SOBQ, discriminate function analysis was used to deter-
mine if the C-SOBQ could distinguish categorical dependent
variables or groupings of COPD patients. The group mem-
berships of the COPD classification, the MMRC levels, and the
quartiles of the BODE index were analysed using the total
scores of C-SOBQ as the independent variable.Wilks’ lambda
is a statistic used in particular in discriminant factor analysis
as a measure of class separation. A small (close to 0) value
means that the groups are well separated where a large
(close to 1) value means that they are poorly separated.
Results
A total of 115 participants were recruited to test the
criterion-related and discriminative validities, including
107 males and eight females. The patients were aged
51e89 years with a mean age of 73.92 years. They included
patients at GOLD COPD classification Stages IeIV and MMRC
scales 0e4. The mean of the patients’ lung function
impairment in terms of FEV1/FVC was 48.27% (SD 13.49).
The BODE index values ranged from 1 to 10 with a mean of
4.17. The C-SOBQ score ranged from 0 to 99, with an
average score of 40.83 units (Table 1).
The ICC obtained in this study was 0.915 (nZ 22) which
indicates good testeretest reliability (Portney & Watkins,
2000).
In terms of functional classification measures, there
were significant positive correlations between the total
Table 2 Correlation Matrix of C-SOBQ with Other Crite-
rion Parameters.
Criterion-related parameter Spearman’s Rho coefficient











Note. 6MWD Z 6-minute walking distance; BMI Z body mass
index; COPD Z chronic obstructive pulmonary disease;
C-SOBQ Z Chinese version of the Shortness of Breath Ques-
tionnaire; FEV1 Z forced expiratory volume in 1 second;
FVC Z forced vital capacity; FEV1 % predicted Z predicted
value of forced expiratory volume in 1 second; FVC %
predicted Z predicted value of forced vital capacity;
GOLDZ Global Initiative for Chronic Obstructive Lung Disease;
MMRC Z Modified Medical Research Council Dyspnoea Scale.
*p  .01.
Chinese shortness of breath questionnaire 79C-SOBQ score and the MMRC scale (r Z .687), GOLD COPD
stage (r Z .581), and BODE index (r Z .76) (Table 2).
Looking at physiological measures of disease severity, there
was a significant negative correlation between the total C-
SOBQ score and the FEV1/FVC, FEV1, FVC, and respective
predicted values (rZ .415 to .63). In terms of measures
of physical wellness, significant negative correlations were
also found between the C-SOBQ and BMI (r Z .314), and
6MWD (r Z .59). However, age had no significant corre-
lation with C-SOBQ score.
The regression analysis showed (Table 3) that only the
BODE index, the MMRC scale, and the 6MWD yielded sig-
nificant results and predicted the C-SOBQ total score
(B Z 0.077e9.022, standard error (SE) Z 0.018e2.446,
tZ 4.271e3.689, p < .05). The BODE index accounted for
54.8% of the total variance in the C-SOBQ total score. After
adding the 6MWD and the MMRC to the regression model,
these three factors accounted for 63.0% of the total var-
iance in the C-SOBQ total score. The final regression
equation for predicting the SOBQ total score was devised
as: C-SOBQ Z 35.040 þ 3.104 (BODE index)  0.077
(6MWD) þ 9.022 (MMRC scale).
In terms of the discriminant analysis, for the COPD
classification (Table 4), the group mean difference ofTable 3 Prediction of the C-SOBQ Total Score.
B SE t
(Constant) 35.040 8.000 4
BODE Index 3.104 1.165 2
6MWD 0.077 0.180 4
MMRC Scale 9.022 2.446 3
Note. 6MWD Z 6-minute walking distance; C-SOBQ Z Chinese versi
Medical Research Council Dyspnoea Scale; Sig. Z p value; * & 0.001.C-SOBQ score was the reference for prediction and was
statistically significant for the grouping (Wilks’
lambdaZ .681, dfZ 3, p < .001). For the MMRC levels, the
group mean difference of the C-SOBQ score was also shown
to be a significant predictor for the MMRC levels grouping
(Wilks’ lambda Z .518, df Z 3, p < .001). Finally, for the
quartiles of the BODE index, the discriminative validity for
the group mean differences of C-SOBQ to BODE index
grouping was fair (Wilks’ lambdaZ .482, dfZ 3, p < .001).
By using the total C-SOBQ score to predict the classi-
fication in COPD, MMRC, and BODE index quartiles (Table 5),
the results of the discriminant analysis showed that 40.0%
of the COPD stage, 41.7% of MMRC levels, and 50.4% of the
quartiles of BODE index of the original cases were correctly
classified.
Discussion
In this study, the C-SOBQ showed high testeretest reli-
ability, consistent with one previous study on the original
version of the questionnaire (Eakin, Sassi-Dambron, & Ries,
1995). The present study also indicated that a self-
administered version of the questionnaire with pictorial
enhancement did not alter the testeretest reliability of the
instrument; furthermore, this approach requires little in-
struction in administration and so might be usefully applied
among the illiterate, and across populations from different
languages and cultures.
In terms of the criterion-related validity, the strongest
correlation was found between the C-SOBQ and the BODE
index, indicating that C-SOBQ has the potential to act as
a good evaluation tool to determine COPD mortality.
A good correlation was also obtained between the C-SOBQ
and MMRC. This could be explained by the fact that both
instruments employ similar constructs to measure dysp-
noea, with MMRC looking at functional dyspnoea levels and
C-SOBQ the dyspnoea levels specifically related to corre-
sponding ADL activities. A moderate correlation was found
between the C-SOBQ score and GOLD COPD classification,
reflecting that the patient’s subjective functional perfor-
mance is actually correlated with physiological impair-
ment as shown by the spirometry lung function test. In
terms of the patient’s actual functional performance,
a strong correlation was found between the C-SOBQ and
the 6MWT. This is not surprising as the 6MWT measures the
patient’s actual exercise capacity which can be highly
limited by dyspnoea. This result is consistent with that
found in previous studies of the SOBQ and 6MWT by Eakin
et al. (1995). A fair correlation was observed between the
C-SOBQ and lung function test, with the result beingSig. R R2




on of the Shortness of Breath Questionnaire; MMRC Z Modified
Table 4 Prediction of COPD Stage MMRC Level and the
Quartiles of the BODE Index by Total Score of C-SOBQ.
Mean SD n
COPD stage
1 10.43 9.20 7
2 28.00 24.11 39
3 42.97 23.20 39
4 61.83 21.21 30
MMRC
0 3.40 3.21 5
1 24.63 21.08 41
2 40.38 20.70 34
3 67.39 16.70 28
4 58.43 22.30 7
BODE quartiles
Q1 (0e2) 19.35 18.32 34
Q2 (3e4) 29.61 19.90 28
Q3 (5e6) 53.30 19.36 27
Q4 (7e10) 68.08 18.11 26
Note. COPD Z chronic obstructive pulmonary disease;
C-SOBQ Z Chinese version of the Shortness of Breath Ques-
tionnaire; MMRCZ Modified Medical Research Council Dyspnoea
Scale; SD Z standard deviation.
80 A. Fung et al.similar to that of a study by Fong et al. (2001) on lung
function impairment and functional performance. This
could be explained by the observation that patients often
compensate for their ADL participation by using adaptive
techniques to minimise dyspnoea in spite of lung function
decline.Table 5 Classification of COPD Stage, MMRC Level and BODE Q
COPD stage GOLD: predicted group membership, n
I II
I 6 (85.7) 1 (14.3)
II 18 (46.2) 11 (28.2)
III 5 (12.8) 12 (30.8)
IV 1 (3.3) 4 (13.3)
40.0% of original grouped cases correctly classified
MMRC MMRC: predicted group membership, n (%)
0 1 2
0 5 (100) 0 (0) 0 (0)
1 18 (43.9) 13 (31.7) 4 (9.
2 3 (8.8) 11 (32.4) 9 (26
3 0 1 (3.6) 3 (10
4 0 1 (14.3) 1 (14
41.7% of original grouped cases correctly classified
BODE quartile BODE quartiles: predicted group me
0e2 3e4
Q1 (0e2) 26 (76.5) 3 (8.8)
Q2 (3e4) 15 (53.6) 7 (25.0)
Q3 (5e6) 1 (3.7) 9 (33.3)
Q4 (7e10) 0 3 (11.5)
50.4% of original grouped cases correctly classified
Note. COPD Z chronic obstructive pulmonary disease; C-SOBQ Z
GOLD Z Global Initiative for Chronic Obstructive Lung Disease; MMRCAge and BMI were found to have relatively low correla-
tions with C-SOBQ. It is commonly observed that many pa-
tients, even those who are very elderly or have a low BMI,
can still perform functionally well in terms of ADL. The
regression results demonstrated good agreement with the
results of the correlation analysis, showing that the BODE
index, MMRC scale, and 6MWD are valid predictors of
C-SOBQ. In fact, all three are actually essential components
of the evaluation of most COPD cases in a pulmonary
rehabilitation programme. These results indicate that
C-SOBQ is complementary to each of them and the infor-
mation it generates is specifically important for occupa-
tional therapists as it directly reflects the patient’s ADL
functioning.
The C-SOBQ was also used to predict group membership
of BODE quartile, GOLD COPD classification, and MMRC
levels using discriminant analysis. The percentage of cases
classified correctly is called the hit ratio. The hit ratio must
be compared not to zero but to the percentage that would
have been correctly classified by chance alone. The results
show that less than 50% of the original group cases (GOLD
COPD stage Z 40.0%, MMRC Z 41.7%) were correctly clas-
sified by the total score of C-SOBQ alone. The percentage of
cases correctly classified by the discriminant analysis
showed a hit ratio below 50% suggesting the discriminative
power of the measure is questionable (Hair, Anderson,
Tatham, & Black, 1995) and warrants further investigation.
The most likely reason for the total score of the C-SOBQ
demonstrating an unsatisfactory discriminative power is
that the sample population was skewed towards high
severity. Among the GOLD COPD classification, only sevenuartiles Using Total Score of C-SOBQ.
(%)
III IV Total
0 (0) 0 (0) 7
2 (5.1) 8 (20.5) 39
7 (17.9) 15 (38.5) 39
3 (10) 22 (73.3) 30
3 4 Total
0 (0) 0 (0) 5
8) 3 (7.3) 3 (7.3) 41
.5) 5 (14.7) 6 (17.6) 34
.7) 19 (67.9) 5 (17.9) 28
.3) 3 (42.9) 2 (28.6) 7
mbership, n (%)
5e6 7e10 Total
3 (8.8) 2 (5.9) 34
4 (14.3) 2 (7.1) 28
6 (22.2) 11 (40.7) 27
4 (15.4) 19 (73.1) 26
Chinese version of the Shortness of Breath Questionnaire;
Z Modified Medical Research Council Dyspnoea Scale.
Chinese shortness of breath questionnaire 81patients were in GOLD Stage I which is small compared with
that of other stages (39 patients in each of Stages II and III
and 30 at Stage IV). In terms of MMRC levels, only five pa-
tients were at Level 0 and seven at Level 5 respectively,
with the majority in Levels 2e4. Many studies suggest that
a ratio of 20 observations for each predictor variable should
be available for the discriminant analysis process to be
completed successfully (Huberty, 1994; Sanchez, 1974).
Nevertheless, the hit ratio of predicting the group
membership of quartiles of the BODE index by C-SOBQ total
score reached 50.7% which is an acceptable percentage.
This implies that the instrument could assist in the prediction
of themortalities and hospitalization of the study population
(Ong, Earnest, & Lu, 2005). Like other prospective observa-
tional studies of patients with COPD, the degree of dispend
and health-status scores are more accurate predictors of the
risk of death than the airflow limitation in the lungs
(Bartolommeo et al., 2010) and our results on the C-SOBQ
and BODE index confirm this observation.
Limitations of the study
Although seven hospitals and outpatient clinics, and two
self-help groups from different geographical regions in
Hong Kong were included in the study to enhance the
representativeness of subject recruitment, the inclusion of
participants was still based on convenience sampling which
limits the generalisability of the results to a larger popu-
lation. Furthermore, there were far fewer participants with
mild COPD in the sample. It is suggested that further studies
should include more patients with milder COPD in commu-
nity settings. The C-SOBQ could also be applied to the study
of patients with other chest diseases, such as pneumo-
coniosis, or those having had lung transplantation, in order
to determine functional dyspnoea level in their ADL.
Conclusion
We have developed a Chinese version of the SOBQ with
pictorial enhancement and shown that it is a reliable and
valid instrument for occupational therapists or other
healthcare professionals to assess the level of dyspnoea
related to ADL among patients with COPD in Hong Kong.
The unique self-administration method of the C-SOBQ
allows it to replace the text version of the SOBQ which
greatly enhances its efficiency and clinical application
among literate and illiterate subjects, and patients from
different cultural and linguistic backgrounds.
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Chinese shortness of breath questionnaire 83Appendix II. The Global Initiative for Chronic
Obstructive Lung Disease (GOLD) guidelines
(GOLD, 2011).Stages Description Classification of severity of
airflow limitation
GOLD I Mild COPD FEV1  80% predicted
GOLD II Moderate COPD 50%  FEV1 80% predicted
GOLD III Severe COPD 30%  FEV1 50% predicted
GOLD IV Very severe COPD FEV1 < 30% predicted
Note. FEV1 Z forced expiratory volume in 1 second.
Variable Points on the BODE Index
0 1 2 3
FEV1 (% predicted) 65 50e64 36e49 35
6-minute
walking test (m)
350 250e349 150e249 149
MMRC Dyspnoea Scale 0e1 2 3 4
Body mass index >21 21
Note. FEV1 Z forced expiratory volume in 1 second.Appendix III. Modified Medical Research
Council (MMRC) Dyspnoea Scale (Eltayara et
al., 1996).Grade Description of breathlessness
0 I only get breathless with strenuous exercise.
1 I get short of breath when hurrying on level ground
or walking up a slight hill.
2 On level ground, I walk slower than people of the
same age because of breathlessness, or have to stop
for breath when walking at my own pace.
3 I stop for breath after walking about 100 yards or
after a few minutes on level ground.
4 I am too breathless to leave the house or I am
breathless when dressing.Appendix IV. Calculation scale of the BODE
Index (Celli et al., 2004).
